tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
LENZ
LENZ Therapeutics
RESEARCH TOOLSreports
Want to see LENZ full AI Analyst Report?

LENZ Therapeutics (LENZ) Ratios

396 Followers

LENZ Therapeutics Ratios

LENZ's free cash flow for Q4 2025 was $0.74. For the 2025 fiscal year, LENZ's free cash flow was decreased by $ and operating cash flow was $-24.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 13.80 13.80 20.36 3.63 4.91
Quick Ratio
 13.80 13.80 20.36 3.63 4.91
Cash Ratio
 1.19 1.19 1.94 1.90 4.68
Solvency Ratio
 -3.80 -3.80 -4.43 -0.43 -0.15
Operating Cash Flow Ratio
 -3.26 -3.26 -5.71 -3.26 -9.26
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 270.81M$ 270.81M$ 200.70M$ -95.84M$ -24.48M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 >-0.01 -0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 >-0.01 -0.01
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.08 1.05 -0.76 -1.94
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.01 0.01 0.06 0.04 0.03
Net Debt to EBITDA
 0.28 0.27 0.38 0.48 4.22
Profitability Margins
Gross Profit Margin
97.16%97.81%0.00%0.00%100.00%
EBIT Margin
-466.00%-477.46%0.00%0.00%-69.89%
EBITDA Margin
-465.06%-477.46%0.00%0.00%-69.83%
Operating Profit Margin
-477.46%-477.46%0.00%0.00%-69.89%
Pretax Profit Margin
-427.62%-427.62%0.00%0.00%-69.76%
Net Profit Margin
-430.25%-430.25%0.00%0.00%-72.07%
Continuous Operations Profit Margin
-430.25%-430.25%0.00%0.00%-72.07%
Net Income Per EBT
100.62%100.62%100.00%99.74%103.32%
EBT Per EBIT
89.56%89.56%84.91%96.85%99.82%
Return on Assets (ROA)
-26.85%-26.85%-23.12%-99.42%-23.03%
Return on Equity (ROE)
-37.47%-28.88%-24.39%75.47%44.73%
Return on Capital Employed (ROCE)
-32.01%-32.01%-28.60%-139.66%-27.99%
Return on Invested Capital (ROIC)
-32.01%-32.01%-28.53%-138.93%-27.91%
Return on Tangible Assets
-26.85%-26.85%-23.12%-99.42%-23.03%
Earnings Yield
-28.45%-17.81%-8.10%-69.28%-8.78%
Efficiency Ratios
Receivables Turnover
 7.86 7.86 0.00 0.00 0.00
Payables Turnover
 0.13 0.10 0.01 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 53.76
Asset Turnover
 0.06 0.06 0.00 0.00 0.32
Working Capital Turnover Ratio
 0.08 0.08 0.00 0.00 0.55
Cash Conversion Cycle
 -2.75K -3.59K -26.79K 0.00 0.00
Days of Sales Outstanding
 46.45 46.45 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 2.80K 3.64K 26.79K 0.00 0.00
Operating Cycle
 46.45 46.45 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.23 -2.40 -2.79 -7.41 -11.22
Free Cash Flow Per Share
 -2.25 -2.43 -2.81 -7.42 -12.06
CapEx Per Share
 0.03 0.03 0.02 <0.01 0.84
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.01 1.00 1.07
Dividend Paid and CapEx Coverage Ratio
 -83.64 -83.64 -0.19 -2.01K -13.34
Capital Expenditure Coverage Ratio
 -83.64 -83.64 -126.90 -2.01K -13.34
Operating Cash Flow Coverage Ratio
 -197.63 -197.63 -43.01 -183.53 -351.92
Operating Cash Flow to Sales Ratio
 -3.62 -3.62 0.00 0.00 -5.87
Free Cash Flow Yield
-24.03%-15.18%-9.74%-59.81%-76.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.55 -5.61 -12.34 -1.44 -11.39
Price-to-Sales (P/S) Ratio
 15.41 24.15 0.00 0.00 8.21
Price-to-Book (P/B) Ratio
 1.02 1.62 3.01 -1.09 -5.10
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.20 -6.59 -10.26 -1.67 -1.30
Price-to-Operating Cash Flow Ratio
 -4.21 -6.66 -10.34 -1.67 -1.40
Price-to-Earnings Growth (PEG) Ratio
 0.34 -0.26 0.15 -0.08 -0.22
Price-to-Fair Value
 1.02 1.62 3.01 -1.09 -5.10
Enterprise Value Multiple
 -3.03 -4.79 -11.98 -0.91 -7.54
Enterprise Value
 266.45M 436.18M 595.61M 66.19M 78.96M
EV to EBITDA
 -3.00 -4.79 -11.98 -0.91 -7.54
EV to Sales
 13.96 22.85 0.00 0.00 5.26
EV to Free Cash Flow
 -3.81 -6.23 -9.95 -1.10 -0.83
EV to Operating Cash Flow
 -3.85 -6.31 -10.03 -1.10 -0.90
Tangible Book Value Per Share
 9.15 9.87 9.59 -11.38 -3.08
Shareholders’ Equity Per Share
 9.15 9.87 9.59 -11.38 -3.08
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 <0.01 -0.03
Revenue Per Share
 0.61 0.66 0.00 0.00 1.91
Net Income Per Share
 -2.64 -2.85 -2.34 -8.59 -1.38
Tax Burden
 1.01 1.01 1.00 1.00 1.03
Interest Burden
 0.92 0.90 1.00 0.97 1.00
Research & Development to Revenue
 0.98 0.98 0.00 0.00 1.41
SG&A to Revenue
 4.77 4.77 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.66 0.66 0.00 0.00 0.00
Income Quality
 0.84 0.84 1.19 0.86 0.87
Currency in USD